Salbutamol

Novolizer Salbutamol Meda, Salbutamol Glenmark, Salbutamol Noridem, Salbutamol Sandoz · ATC code R03CC02

Also known as: Salbutamolo, Albuterol Sulfate · Brand names: Apsomol N Für Erwachsene Und Kinder Ab, Bronchospray Autohaler, Bronchospray Novo, Cyclocaps, Fertiginhalat, Inhalat, Novolizer, Salbu Easyhaler, Salbubronch Elixier, Salbubronch Forte, Salbuhexal Dosieraerosol, Salbuhexal N Dosieraerosol, Salbuhexal N Hexal Ag, Salbulair N, Sultanol Dosier-Aerosol …

Key facts
Active substance
Salbutamol
ATC code
R03CC02
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-11-03

Key facts

Salbutamol (US name albuterol) is a short-acting beta-adrenergic agonist bronchodilator. Per the US label the metered-dose inhalation aerosol is used to treat or prevent bronchospasm and to prevent exercise-induced bronchospasm in patients 4 years of age and older.

What it is used for

  • Treatment or prevention of bronchospasm in reversible obstructive airway disease, patients 4 years of age and older
  • Prevention of exercise-induced bronchospasm, patients 4 years of age and older

Dosing

  • Adults and children 4 years and older: two inhalations every 4 to 6 hours; in some patients one inhalation every 4 hours may be sufficient
  • More frequent administration or a larger number of inhalations is not recommended
  • Exercise-induced bronchospasm: two inhalations 15 to 30 minutes before exercise
  • Each actuation delivers 90 mcg of albuterol base from the mouthpiece; shake well before each spray
  • Prime with three sprays before first use or if unused for more than 2 weeks; clean the mouthpiece at least once a week

Contraindications

  • History of hypersensitivity to albuterol or any other component of the product

Important warnings

  • Paradoxical bronchospasm, possibly life threatening and often with the first use of a new canister; discontinue immediately
  • Needing more doses than usual signals deteriorating asthma; reassess treatment, including the need for anti-inflammatory therapy such as corticosteroids
  • Cardiovascular effects (pulse, blood pressure, ECG changes such as QTc prolongation); caution in coronary insufficiency, arrhythmias and hypertension
  • Fatalities reported with excessive use of inhaled sympathomimetics; do not exceed the recommended dose
  • Immediate hypersensitivity reactions (urticaria, angioedema, rash, anaphylaxis); significant, usually transient hypokalemia
  • Caution in convulsive disorders, hyperthyroidism and diabetes mellitus

Side effects

  • In the adult trial: pharyngitis, headache, rhinitis, tachycardia, pain, dizziness
  • Tremor, nervousness and headache most frequent in cumulative-dose studies
  • Postmarketing: palpitations, arrhythmias (including atrial fibrillation), hypertension or hypotension, insomnia, muscle cramps, throat irritation, hypokalemia, hyperglycemia

Interactions

  • Other short-acting sympathomimetic aerosol bronchodilators: do not use concomitantly; other adrenergic drugs with caution
  • Beta-blockers block the effect and may cause severe bronchospasm in asthma; if unavoidable, consider cardioselective agents with caution
  • Non-potassium sparing diuretics (loop, thiazide): ECG changes and hypokalemia may worsen; consider monitoring potassium
  • Digoxin: serum digoxin levels may fall; evaluate levels
  • MAO inhibitors or tricyclic antidepressants, or within 2 weeks of stopping them: extreme caution because cardiovascular effects may be potentiated

Pregnancy and breastfeeding

  • Available human data do not consistently show a risk of major birth defects or miscarriage; poorly controlled asthma itself raises maternal and neonatal risks
  • During labor, use only when benefits clearly outweigh the risk (possible interference with uterine contractility); not approved for pre-term labor
  • No data on albuterol in human milk; plasma levels after inhalation are low

Summary of the official product information, written with AI on 2026-11-03. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

This product has no separate US patient information.

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Germany

  • Apsomol N Für Erwachsene Und Kinder AbJensonr+ (Ireland) Ltd · 1 register entry
  • Bronchospray AutohalerJensonr+ (Ireland) Ltd · 1 register entry
  • Bronchospray NovoJensonr+ (Ireland) Ltd · 1 register entry
  • CyclocapsPb Pharma Gmbh · 1 register entry
  • FertiginhalatStadapharm Gmbh · 2 register entries
  • InhalatStadapharm Gmbh · 1 register entry
  • NovolizerViatris Healthcare Gmbh · 1 register entry
  • Salbu EasyhalerOrion Corporation · 1 register entry
  • Salbubronch ElixierInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
  • Salbubronch ForteInfectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim · 1 register entry
  • Salbuhexal DosieraerosolHexal Ag · 1 register entry
  • Salbuhexal N DosieraerosolHexal Ag · 1 register entry
Show all 20 brand names
  • Salbuhexal N Hexal AgHexal Ag · 1 register entry
  • Salbulair NTeva Gmbh · 1 register entry
  • Salbutamol1 A Pharma Gmbh, Ratiopharm Gmbh, Aliud Pharma Gmbh, Glenmark Arzneimittel Gmbh, Noridem Enterprises Ltd, Neutec Inhaler Ireland Ltd, Teva Gmbh · 10 register entries
  • Sultanol Dosier-AerosolGlaxosmithkline Gmbh & Co. Kg · 1 register entry
  • Sultanol FertiginhalatGlaxosmithkline Gmbh & Co. Kg · 1 register entry
  • Sultanol Forte FertiginhalatGlaxosmithkline Gmbh & Co. Kg · 1 register entry
  • Sultanol InhalationslösungGlaxosmithkline Gmbh & Co. Kg · 1 register entry
  • Ventilastin NovolizerViatris Healthcare Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03

Austria

  • Novolizer Salbutamol MedaViatris Healthcare Limited · 1 register entry
  • Salbutamol GlenmarkGlenmark Arzneimittel Gmbh · 1 register entry
  • Salbutamol NoridemNoridem Enterprises Ltd · 1 register entry
  • Salbutamol SandozSandoz Gmbh · 1 register entry
  • SultanolGlaxosmithkline Pharma Gmbh. · 3 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-03

Turkey

  • BerastBERKO İLAÇ VE KİMYA SAN. A.Ş. · 2 register entries
  • BronkasNOBEL İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
  • MetrastSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
  • Salbutam SRNOBEL İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • Salodil SRULKAR KİMYA SAN. VE TİC. A.Ş. · 4 register entries
  • SalresDEVA HOLDİNG A.Ş. · 1 register entry
  • VentolinGLAXOSMİTHKLİNE İLAÇLARI SAN. VE TİC. A.Ş. · 1 register entry
  • VentosalBİLİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
  • VentubolLİLYUM İLAÇ VE KİMYA SAN. TİC. LTD. ŞTİ. · 5 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-03

Brand names in 27 more European countries
Belgium
Airomir, Novolizer Salbutamol, Salbutamol Neutec, Salbutamol Noridem, Salbutamol Novolizer Meda Pharma, Ventolin
Bulgaria
Buto-Asma, Вентолин, Екосал Инхалер, Салбутамол Wzf, Салбутамол Софарма
Croatia
Antamenys, Salbutamol Pliva
Cyprus
Brodilaten Noridem Enterprises, Medolin, Ventolin
Czechia
Buventol Easyhaler, Ecosal Inhaler, Salbutamol Noridem, Salbutamol Polpharma, Ventolin
Denmark
Airomir, Airsalb, Buventol Easyhaler, Salamol, Salbutamol "neutec", Salbutamol Noridem, Salbutamol Teva, Ventoline
Estonia
Buventol Easyhaler, Ventolin
Finland
Airomir, Buventol Easyhaler, Salbutamol Neutec, Ventilastin Novolizer, Ventoline
France
Airomir Autohaler, Salbumol, Salbutamol, Ventilastin Novolizer, Ventoline
Greece
Aerolin, Asthmotrat, Brodilaten
Hungary
Buventol Easyhaler, Ventolin Evohaler
Iceland
Salbutamol Neutec, Ventoline
Ireland
Brodilaten, Salamol, Salbutamol Neutec, Ventolin
Italy
Broncovaleas, Salbutamol Noridem, Salbutamolo Glenmark, Salbutamolo Noridem, Salbutamolo Sandoz, Ventolin
Latvia
Salbutamol Inteli, Ventolin
Lithuania
Salbutamol Inteli, Ventolin
Luxembourg
Airomir, Novolizer Salbutamol, Ventolin
Malta
Ventoaldo, Ventolin
Netherlands
Airomir Autohaler, Airomir Inhalator, Salamol Steri-Neb, Salbutamol, Ventolin
Norway
Airomir, Buventol Easyhaler, Salbutamol Neutec, Ventoline
Poland
Aspulmo, Buventol Easyhaler, Lerhasa, Salbutamol Hasco, Salbutamol Wzf, Ventolin
Portugal
Salbutamol Gp, Salbutamol Noridem, Salbutamol Novolizer, Salbutamol Sandoz, Ventilan
Romania
Salbutamol, Ventolin
Slovakia
Salbutamol Noridem, Ventolin
Slovenia
Antamenys, Ventolin
Spain
Aldobronquial, Salbuair, Salbutamol Aldo-Unión, Salbutamol Glenmark, Salbutamol Neutec, Salbutamol Sandoz, Ventoaldo, Ventolin
Sweden
Airomir, Airsalb, Buventol Easyhaler, Salbutamol, Ventilastin Novolizer, Ventoline

EMA – Article 57 product data (EU/EEA), 2026-11-03

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Albuterol Sulfate (Armstrong Pharmaceuticals, Inc.) – Prescribing Information, 2026-08-06. DailyMed (NLM), 2026-11-03. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17858afa-dcdf-4612-b475-3b6baadfb639
  2. EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-11-03. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-03. https://www.titck.gov.tr/dinamikmodul/85

Editorial: Medelix editorial team · last updated 2026-11-03 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.